Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine and Bupivacaine for Postoperative Pain After Nasal Closed Reduction
NCT03733275Completed
- Sponsor
- The Catholic University of Korea
- Start
- Dec 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of lidocaine 10% oropharyngeal spray and bupivacaine in nasal fracture (2 arms), sponsored by The Catholic University of Korea. Primary endpoint: Postoperative pain in recovery room. Started Dec 2018; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spraybupivacaine
03
Conditions
nasal fracture
Beyond the preview
Go deeper on NCT03733275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03733275.